Search Results - André Serra-Roma

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study by Renaud Felten, Nan Shen, Julia Weinmann-Menke, Ana Malvar, Peter Gergely, Tamas Shisha, Carole Sips, André Serra-Roma, Markus Weiss, Rambabu Danekula, Jan Rohr

    Published in RMD Open (2025-08-01)
    Get full text
    Article


Search Tools: